These advancements, such as the combination of semaglutide and bimagrumab, the development of triple-hormone receptor agonists like retratrutide, and the exploration of alternative delivery methods, hold promise for improving the lives of millions of people struggling with obesity and its related health complications
2024;doi:10.1111/add.16679
Key genetic variantsincluding GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313affect receptor sensitivity and signaling strength in your hunger pathways
PlexusDx supports transparent communication with your medical team throughout your treatment journey
This innovative therapy, delivered under the care of Dr
The phase 3 OASIS 1 trial investigated high dose oral semaglutide in participants with overweight or obesity, but without T2D (58)